{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:25:39Z","timestamp":1780104339381,"version":"3.54.0"},"reference-count":31,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R35 CA253187"],"award-info":[{"award-number":["R35 CA253187"]}]},{"name":"NIH","award":["P50 CA116201"],"award-info":[{"award-number":["P50 CA116201"]}]},{"DOI":"10.13039\/100001006","name":"BCRF","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Carriers of a pathogenic variant (PV) in BRCA1 face a high risk of breast cancer. This study estimated the risk of developing breast cancer according to mutation type and location. Methods: BRCA1 carriers with no personal history of breast cancer or bilateral mastectomy were included. Detailed information on clinical and family history was collected by questionnaire. Survival analysis was used to estimate 15-year cumulative risk according to PV type and location. Results: A total of 3677 BRCA1 carriers were followed for a mean of 7.2 years (range 0.1\u201315.0 years); 481 incident breast cancers were documented. Overall, the 15-year cumulative incidence was 25%. Risk estimates varied by exon, ranging from 9% (exon 21) to 19% (exon 12) to 36% (exon 15); however, strata were small. Carriers of four founder mutations common in Eastern Europe (c.5263_5264insC, c.181T &gt; G, c.66_67delAG and c.4034delA) experienced a lower-than-expected cancer risk (15.9\u201324.4%) compared to other PVs (28.8%) (p = 0.02). Conclusions: Although our data suggests some variability in penetrance based on specific BRCA1 PV, this was based on a large number of founder mutations. Breast cancer management strategies should continue to be based on comprehensive risk assessment.<\/jats:p>","DOI":"10.3390\/curroncol32120705","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:52:59Z","timestamp":1765813979000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1"],"prefix":"10.3390","volume":"32","author":[{"given":"Joanne","family":"Kotsopoulos","sequence":"first","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4614-9261","authenticated-orcid":false,"given":"Adriana I.","family":"Apostol","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Dipartimento Scienze della Salute della Donna, Del Bambino e di Sanit\u00e0 Pubblica, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Universita\u2019 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Metcalfe","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Bloomberg Faculty of Nursing, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9648-4213","authenticated-orcid":false,"given":"Dimitri","family":"Jorgji","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2819-3057","authenticated-orcid":false,"given":"Cezary","family":"Cybulski","sequence":"additional","affiliation":[{"name":"Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3643-2871","authenticated-orcid":false,"given":"Jacek","family":"Gronwald","sequence":"additional","affiliation":[{"name":"Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2931-3003","authenticated-orcid":false,"given":"Jan","family":"Lubinski","sequence":"additional","affiliation":[{"name":"Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Moller","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, 0379 Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-8674","authenticated-orcid":false,"given":"Raymond H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8907-7853","authenticated-orcid":false,"given":"Amber","family":"Aeilts","sequence":"additional","affiliation":[{"name":"Division of Human Genetics, The Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3490-3585","authenticated-orcid":false,"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-2475","authenticated-orcid":false,"given":"Tuya","family":"Pal","sequence":"additional","affiliation":[{"name":"Vanderbilt-Ingram Cancer Center, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Bordeleau","sequence":"additional","affiliation":[{"name":"Department of Oncology, Juravinski Cancer Centre and McMaster University, Hamilton, ON L8V 5C2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-2933","authenticated-orcid":false,"given":"Beth Y.","family":"Karlan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian F.","family":"Singer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, 1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[{"name":"McGill Program in Cancer Genetics, Department of Oncology, McGill University, Montreal, QC H3A 0G4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fergus J.","family":"Couch","sequence":"additional","affiliation":[{"name":"Division of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Zakalik","sequence":"additional","affiliation":[{"name":"Cancer Genetics Program, Beaumont Hospital, Royal Oak, MI 48073, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5688-2194","authenticated-orcid":false,"given":"Robert","family":"Fruscio","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Milan Bicocca, 20126 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Tung","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Sun","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-4801","authenticated-orcid":false,"given":"Alvaro N.","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Centre, Tampa, FL 33612, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5798-0626","authenticated-orcid":false,"given":"Steven A.","family":"Narod","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad R.","family":"Akbari","sequence":"additional","affiliation":[{"name":"Women\u2019s College Research Institute, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada"},{"name":"Institute of Medical Science, Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/nar\/gkl010","article-title":"BRCA1: Cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution","volume":"34","author":"Deng","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.7150\/jca.30410","article-title":"BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J. Cancer"},{"key":"ref_3","unstructured":"Casaubon, J.T., Kashyap, S., and Regan, J.P. (2025). BRCA1 and BRCA2 Mutations. StatPearls, StatPearls Publishing."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: A combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am. J. Human Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"ref_6","unstructured":"(2025, September 16). Available online: https:\/\/www.brcaexchange.org."},{"key":"ref_7","first-page":"329","article-title":"Variation in BRCA1 cancer risks by mutation position","volume":"11","author":"Thompson","year":"2002","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.2014.5985","article-title":"Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer","volume":"313","author":"Rebbeck","year":"2015","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"R42","DOI":"10.1186\/bcr3138","article-title":"Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"14","author":"Kotsopoulos","year":"2012","journal-title":"Breast Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.18632\/oncotarget.13423","article-title":"The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation","volume":"8","author":"Toss","year":"2017","journal-title":"Oncotarget"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41698-024-00741-4","article-title":"Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing","volume":"8","author":"Pal","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"39","author":"Rebbeck","year":"2018","journal-title":"Human Mutat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_14","unstructured":"(2025, September 16). Available online: https:\/\/www.ncbi.nlm.nih.gov\/clinvar."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.annonc.2025.04.010","article-title":"Association of gene variant type and location with breast cancer risk in the general population","volume":"36","author":"Akamandisa","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14898","DOI":"10.3390\/ijms131114898","article-title":"A DNA repair BRCA1 estrogen receptor and targeted therapy in breast cancer","volume":"13","author":"Ratanaphan","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Poorbagher, M.R.M., and Santarosa, M. (2025). Beyond repair: Expanding roles of BRCA1 in RNA processing and cancer. Biochim. Biophys. Acta Rev. Cancer, 1880.","DOI":"10.1016\/j.bbcan.2025.189499"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32863","DOI":"10.1074\/jbc.271.51.32863","article-title":"The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor","volume":"271","author":"Chen","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Clark, S.L., Rodriguez, A.M., Snyder, R.R., Hankins, G.D., and Boehning, D. (2012). Structure-Function Of The Tumor Suppressor BRCA1. Comput. Struct. Biotechnol. J., 1.","DOI":"10.5936\/csbj.201204005"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Plakhins, G., Irmejs, A., Gardovskis, A., Subatniece, S., Rozite, S., Bitina, M., Keire, G., Purkalne, G., Teibe, U., and Trofimovics, G. (2011). Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia. BMC Med. Genet., 12.","DOI":"10.1186\/1471-2350-12-147"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1136\/jmg.2004.019430","article-title":"A protein truncating BRCA1 allele with a low penetrance of breast cancer","volume":"41","author":"Gorski","year":"2004","journal-title":"J. Med. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"R728","DOI":"10.1186\/bcr1282","article-title":"High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area","volume":"7","author":"Pohlreich","year":"2005","journal-title":"Breast Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","article-title":"Founder BRCA1\/2 mutations in the Europe: Implications for hereditary breast-ovarian cancer prevention and control","volume":"1","year":"2010","journal-title":"EPMA J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1095-198","article-title":"The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals","volume":"11","author":"Struewing","year":"1995","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-020-05827-8","article-title":"Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients","volume":"184","author":"Sokolenko","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/cge.12360","article-title":"Recurrent mutations of BRCA1 and BRCA2 in Poland: An update","volume":"87","author":"Szwiec","year":"2015","journal-title":"Clin. Genet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13353-011-0040-6","article-title":"Prevalence of the most frequent BRCA1 mutations in Polish population","volume":"52","author":"Brozek","year":"2011","journal-title":"J. Appl. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Dodova, R.I., Mitkova, A.V., Dacheva, D.R., Hadjo, L.B., Vlahova, A.I., Hadjieva, M.S.T., Valev, S.S., Caulevska, M.M., Popova, S.D., and Popov, I.E. (2015). Spectrum and frequencies of BRCA1\/2 mutations in Bulgarian high risk breast cancer patients. BMC Cancer, 15, Erratum in BMC Cancer 2017, 17, 195.","DOI":"10.1186\/s12885-015-1516-2"},{"key":"ref_29","unstructured":"National Comprehensive Cancer Network (NCCN) Guidelines (2025, November 17). Genetic\/Familial High-Risk Assessment: Breast, Ovarian and Pancreatic. Version 2.2026. Available online: https:\/\/www.nccn.org."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.23.02225","article-title":"Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_31","unstructured":"(2025, June 07). American Society of Breast Surgeons (ASBrS). Available online: https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-Genetic-Testing-for-Hereditary-Breast-Cancer.pdf."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:20:55Z","timestamp":1765948855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/32\/12\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["curroncol32120705"],"URL":"https:\/\/doi.org\/10.3390\/curroncol32120705","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}